Macrophage Pharma’s CEO, Søren Bregenholt discusses company strategy with pharmaphorum

Executive Summary
Richard Staines spoke with Soren Bregenholt, the new CEO of Macrophage Pharma, about the company’s strategy encompassing both immune oncology and inflammatory diseases.

To read the full article, go on https://bit.ly/398smQc